India, July 14 -- Monogram Technologies Inc. (MGRM) shares surged 74.16 percent to $5.73 on Monday after announcing its acquisition by Zimmer Biomet Holdings in a cash-and-contingent deal valued up to $16.41 per share. The upfront payment of $4.04 per share reflects an equity value of approximately $177 million, with an additional $12.37 per share tied to future development, regulatory, and revenue milestones through 2030.
The stock opened at $5.51 and hit an intraday high of $6.02, with volume soaring to over 12.5 million shares compared to its average of around 60,000 on the Nasdaq.
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1568189509843-0'); });
Monogram's FDA-cleared robotic total knee arthroplasty technology and ...